Explore PMOS Research
Search 20,710 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies8,101–8,120 of 20,710
All studies
P-601 Comparison of adverse obstetric outcomes in women with the hyperandrogenic syndromes, polycystic ovary syndrome and Cushing’s syndrome: an evaluation of a population database
THU137 Body Mass Index Relates To Quality Of Life In Adolescents With Polycystic Ovary Syndrome
Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome
Recombinant follitropins in IVF programs in patients with polycystic ovary syndrome
Polycystic Ovary Syndrome (PCOS) Inhibitory Drug Screening from Selective Inositols
Dietary Intake and Their Relationship with Hormones and Body Composition Characteristics in Obese and Non-Obese Women Having Polycystic Ovary Syndrome
Breaking the psychological silence: An overview of PCOS.
FRI280 Partial Loss Of KNDy Neurons In Prenatally Androgen Treated Female Rats Alters The LH Secretion And Ovarian Morphology In A Model Of Polycystic Ovary Syndrome
Metformin versus Orlistat for The Management of Infertile Obese Patients with polycystic Ovary Syndrome; A Randomized Controlled Trial
Studying the Effect of Curcumin (Standard & Supplements) and Zinc on the Concentrations of Glucose, Insulin, HOMA-IR, and Anti-Mullerian Hormone in PCOS-Model Rats
Association between Childhood Obesity and Polycystic Ovary Syndrome: A Two-Sample Mendelian Randomization Study
Association between Glucose Metabolism and Oral Combined Contraceptive Pills or Cyclic Progestin in Thai Women with Polycystic Ovary Syndrome: A 3-year Observational Study
Validating Rat Model of Polycystic Ovary Syndrome Induced Non-Alcoholic Fatty Liver Disease: Role of Hyperandrogenism and Insulin Resistance
Holistic treatment for PCOS patients: patient perspective, physicians perspective
Endothelial cell-specific molecule 1 is regulated separately in follicular and serum compartments of PCOS patients: a pilot study.
A study of thyroid function in polycystic ovary syndrome
Effect of human chorionic gonadotropin on pregnancy outcomes in patients with polycystic ovary syndrome undergoing frozen-thaw embryo transfer in hormone replacement therapy cycles: A retrospective cohort study
Metabolic and Cardiovascular Risks in Women with Polycystic Ovary Syndrome: Focus on Type 2 Diabetes, MASLD, and Cardiovascular Disease
Complement C1 Tumor Necrosis Factor-Related Protein 1 is Related to Glucose/Lipid Metabolism in Polycystic Ovary Syndrome Patients
O-094 Management of subfertility in women with PCOS: expectations, problems and solutions